Estrogenic triarylethylene acetic acids: Effect of structural variation on estrogen receptor affinity and estrogenic potency and efficacy in MCF-7 cells

Journal of Medicinal Chemistry

Volumn 39, Issue 24, 1996, Pages 4853-4859

  Ruenitz, Peter C ^a   Bourne, Caryl S ^a   Sullivan, Kelly J ^a   Moore, Susan A ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 [1 (4 HYDROXYPHENYL) 2 PHENYL] 1 BUTENYL]PHENOXYACETIC ACID; ANTIESTROGEN; ESTROGEN RECEPTOR; TAMOXIFEN; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; RECEPTOR AFFINITY;

ANIMALS; BINDING, COMPETITIVE; CELLS, CULTURED; ESTRADIOL; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PHENOXYACETATES; RATS; RECEPTORS, ESTROGEN; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; UTERUS;

EID: 0030459216     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960517e     Document Type: Article

References (37)

1. (a) Eriksen, E. F.; Colvard, D. S.; Berg, N. J.; Graham, M. L.; Mann, K. G.; Spelsberg, T. C.; Riggs, B. L. Evidence of Estrogen Receptors in Normal Hitman Osteoblast-like Cells. Science 1988, 241, 84-86.
2. (b) Oursler, M. J.; Osdoby, P.; Pyfferoen, J.; Riggs, B. L.; Spelsberg, T. C. Avian Osteoclasts as estrogen target cells. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 6613-6617.
3. (c) Brubaker, K. D.; Gay, C. V. Specific Binding of Estrogen to Osteoclast Surfaces. Biochem. Biophys. Res. Commun. 1994, 200, 899-907.
4. (a) Mendelson, M. E.; Karas, R. H. Estrogen and the Blood-vessel Wall. Curr. Opin. Cardiol. 1994, 9, 619-626.
5. (b) Karas, R. H.; Baur, W. E.; Vaneickles, M.; Mendelsohn, M. E. Human Vascular Smooth-muscle Cells Express an Estrogen-receptor Isoform. Febs Lett. 1995, 377, 103-108.
6. Ruenitz, P. C. Drugs for Osteoporosis Prevention: Mechanisms of Bone Maintenance. Curr. Med. Chem. 1995, 2, 791-802.
7. (a) Bignon, E.; Pons, M.; Crastes de Paulet, A.; Doré, J.-C.; Gilbert, J.; Abecassis, J.; Miquel, J.-F.; Ojasoo, T.; Raynaud, J.-P. Effect of Triphenylacrylonitrile Derivatives on Estradiol-receptor Binding and on Human Breast Cancer Cell Growth. J. Med. Chem. 1989, 32, 2092-2103.
8. (b) Robertson, D. W.; Katzenellenbogen, J. A.; Long, D. J.; Rorke, E. A.; Katzenellenbogen, B. S. Tamoxifen Antiestrogens. A Comparison of the Activity, Pharmacokinetics, and Metabolic Activation of the Cis and Trans Isomers of Tamoxifen. J. Steroid Biochem. 1982, 16, 1-13.
9. Examples: (a) Coezy, E.; Borgna, J.-L.; Rochefort, H. Tamoxifen and Metabolites in MCF-7 Cells: Correlation Between Binding to the Estrogen Receptor and Inhibition of Cell Growth. Cancer Res. 1982, 42, 317-323.
10. (b) Hartmann, R. W.; Sinchai, T.; Kranzfelder, G. Anti-proliferative Effects of 1,2-Diphenylethane Oestrogens and Anti-oestrogens on Human Breast Cancer Cells. J. Cancer Res. Clin. Oncol. 1985, 110, 17-24.
11. (c) Ruenitz, P. C.; Bagley, J. R.; Watts, C. K. W.; Hall, R. E.; Sutherland, R. L. Substituted-vinyl Hydroxytriarylethylenes, 1-[4-(2-Diethylamino)ethoxypnenyl]-1-(4-hydroxyphenyl)-2-phenylethylenes: Synthesis and Effects on MCF-7 Breast Cancer Cell Proliferation. J. Med. Chem. 1986, 29, 2511-9.
12. (d) Thompson, E. W.; Katz, D.; Shima, T. B.; Wakeling, A. E.; Lippman, M. E.; Dickson, R. B. ICI-164,384, a Pure Antagonist of MCF-7 Cell Proliferation and Invasiveness. Cancer Res. 1989, 49, 6929-6934.
13. Soto, A. M.; Sonnenschein, C.; Chung, K. L.; Fernandez, M. F.; Olea, N.; Serrano, F. O. The E-Screen Assay as a Tool to Identify Estrogens - an Update on Estrogenic Environmental Pollutants. Environ. Health Perspect. 1995, 103, 113-122.
14. (a) Murphy, C. S.; Langan-Fahey, S. M.; McCague, R.; Jordan, V. C. Structure-function Relationships of Hydroxylated Metabolites of Tamoxifen That Control the Proliferation of Estrogen-responsive T47D Breast Cancer Cells in Vitro. Mol. Pharmacol. 1990, 38, 737-743.
15. 5 Adrenal Steroids. Endocrinology (Baltimore) 1990, 127, 2757-2762.
16. (a) Kohno, H.; Gandini, O.; Curtis, S. W.; Korach, K. S. Antiestrogen Activity in the Yeast Transcription System: Estrogen Receptor Mediated Agonist Response. Steroids 1994, 59, 572-578.
17. (b) Hyder, S. M.; Shipley, G. L.; Stancel, G. M. Estrogen Action in Target-cells - Selective Requirements for Activation of Different Hormone Response Elements. Mol. Cell. Endocrinol. 1995, 112, 35-43.
18. Wilson, S.; Ruenitz, P. C.; Ruzicka, J. A. Estrogen Receptor Affinity and Effects on MCF-7 Cell Growth of Triarylethylene Carboxylic Acids Related to Tamoxifen. J. Steroid Biochem. Mol. Biol. 1992, 42, 613-616.
19. Ruenitz, P. C.; Nanavati, N. T. Identification and Distribution in the Rat of Acidic Metabolites of Tamoxifen. Drug Metab. Dispos. 1990, 18, 645-648.
20. (a) Sato, M.; Rippy, M. K.; Bryant, H. U. Raloxifene, Tamoxifen, Nafoxidine, or Estrogen Effects on Reproductive and Nonreproductive Tissues in Ovariectomized Rats. FASEB J. 1996, 10, 905-912.
21. (b) Ke, H. Z.; Simmons, H. A.; Pirie, C. M.; Crawford, D. T.; Thompson, D. D. Droloxifene, a New Estrogen Antagonist/ Agonist, Prevents Bone Loss in Ovariectomized Rats. Endocrinology (Baltimore) 1995, 136, 2435-2441.
22. For convenience, the trans configurations of unsymmetric triarylethylenes are shown, although each of these is composed of approximately a 1:1 mixture of its trans and cis isomer.
23. (a) Coe, P. L.; Scriven, C. E. Crossed Coupling of Functionalized Ketones by Low Valent Titanium (The McMurry Reaction): a New Stereoselective Synthesis of Tamoxifen. J. Chem. Soc., Perkin Trans. 1 1986, 475-477.
24. (b) Gauthier, S.; Mailhot, J.; Labrie, F. New Highly Stereoselective Synthesis of (Z)-4-Hydroxytamoxifen and (2)-4-Hydroxytoremifene via McMurry Reaction. J. Org. Chem. 1996, 61, 3890-3893.
25. Katzenellenbogen, J. A.; Tatee, T.; Robertson, D. W. Preparation of Tritium-labeled 4-Hydroxy-α-[p-(2-(N-pyrrolidinyl)ethoxy)-phenyl]-α′- nitrostilbene (CN-928), a Biologically Important Metabolite of the Antiestrogen CI-628. J. Labelled Compds. Radiopharm. 1981, 18, 865-879.
26. Carmack, M.; Spielman, M. A. The Willgerodt Reaction In Organic Reactions; Adams, R., Bachmann, W. E., Feiser, L. F., Johnson, J. R., Snyder, H. R., Eds.; Wiley: New York, 1946; Vol. 3, pp 97-98.
27. Izzo, P. T.; Safir, S. R. Preparation of Aliphatic Ketones from Lithium Alkyls and Dimethylamides. J. Org. Chem. 1959, 24, 701-703.
28. Ruenitz, P. C.; Bagley, J. R.; Mokler, C. M. Estrogenic and Antiestrogenic Activity of Monophenolic Analogues of Tamoxifen, (Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine. J. Med. Chem. 1982, 25, 1056-1060.
29. Ruenitz, P. C.; Bagley, J. R.; Nanavati, N. T. Synthesis and Estrogen Receptor Selectivity of 1,1-bis-(4-Hydroxyphenyl)-2-(p-halophenyl)ethylenes. J. Med. Chem. 1988, 31, 1471-1475.
30. Willson, T. M.; Henke, B. R.; Momtahen, T. M.; Charifson, P. S.; Batchelor, K. W.; Lubahn, D. B.; Moore, L. B.; Oliver, B. B.; Sauls, H. R.; Triantafillou, J. A.; Wolfe, S. G.; Baer, P. G. 3-[4-(1,2-Diphenylbut-1-enyl)phenyl]acrylic acid: a Non-steroidal Estrogen with Functional Selectivity for Bone over Uterus in Rats. J. Med. Chem. 1994, 37, 1550-1552.
31. (a) Wang, T. T. Y.; Sathyamoorthy, N.; Phang, J. M. Molecular Effects of Genestein on Estrogen Receptor Mediated Pathways. Carcinogenesis 1996, 17, 271-275.
32. (b) Mäkelä, S.; Davis, V. L.; Tally, W. C.; Korkman, J.; SaLo, L.; Vihko, R.; Santti, R.; Korach, K. S. Dietary Estrogens Act Through Estrogen Receptor Mediated Processes and Show No Antiestrogenicity in Cultured Breast Cancer Cells. Environ. Health Perspect. 1994, 102, 572-578.
33. (a) Brandes, L. J.; Gerrard, J. M.; Bogdanovic, R. P.; Lint, D. W.; Reid, R. E.; LaBeLLa, F. S. Correlation of the Antiproliferative Action of Diphenylmethane-derivative Antiestrogen Binding Site Ligands with Antagonism of Histamine Binding but Not of Protein Kinase C. Cancer Res. 1988, 48, 3954-3958.
34. (b) Brandes, L. J.; Beecroft, W. A.; Hogg, G. R. Stimulation of In Vivo Tumor Growth and Phorbol Ester-induced Inflammation by N,N-Diethyl-2-[4-(phenylmethyl)phenoxy] Ethanamine HCl, a Potent Ligand for Intracellular Histamine Receptors. Biochem. Biophys. Res. Commun. 1991, 179, 1297-1304.
35. Jones, C. D.; Blaszczak, L. C.; Goettel, M. E.; Suarez, T.; Crowell, T. A.; Mabry, T. E.; Ruenitz, P. C.; Srivatsan, V. Antiestrogens. 3. Estrogen Receptor Affinities and Antiproliferative Effects of Phenolic Analogues of Trioxifene, [3,4-Dihydro-2-(4-methoxyphenyl)-1-naphthalenyl][4-[2-(1-pyrrolidinyl)ethoxy] phenyl]methanone. J. Med. Chem. 1992, 35, 931-938.
36. Complete details will appear in a future paper currently in preparation.
37. Butler, W. B. Preparing Nuclei from Cells in Monolayer Cultures Suitable for Counting and for Following Synchronized Cells Through the Cell Cycle. Anal. Biochem. 1984, 141, 70-73.